共 36 条
- [3] Relapsed Myasthenia Gravis after Nivolumab Treatment [J]. INTERNAL MEDICINE, 2018, 57 (13) : 1893 - 1897
- [5] Association Between Programed Cell Death-1 and CD4+ T Cell Alterations in Different Phases of Ischemic Stroke Patients..[J].Zhang Yi;Wei Li;Du Yupeng;Xie Yirui;Wu Wei;Yuan Yuan.Frontiers in cellular neuroscience.2018,
- [6] Neuromyelitis optica spectrum disorder secondary to treatment with anti-PD-1 antibody nivolumab: the first report..[J].Narumi Yoshitsugu;Yoshida Ryohei;Minami Yoshinori;Yamamoto Yasushi;Takeguchi Shiori;Kano Kohei;Takahashi Kae;Saito Tsukasa;Sawada Jun;Terui Hiroya;Katayama Takayuki;Sasaki Takaaki;Ohsaki Yoshinobu.BMC cancer.2018, 1
- [7] Immune-Related Adverse Events Associated with Immune Checkpoint Blockade [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (02): : 158 - 168
- [8] Disruption of myelin leads to ectopic expression of K(V)1.1 channels with abnormal conductivity of optic nerve axons in a cuprizone-induced model of demyelination..[J].Bandita Bagchi;Ahmed Al-Sabi;Seshu Kaza;Dimitri Scholz;Valerie B O'Leary;J Oliver Dolly;Saak V Ovsepian.PLoS ONE.2017, 2
- [10] PD-1 gene polymorphic variation is linked with first symptom of disease and severity of relapsing-remitting form of MS.[J].Edyta Pawlak-Adamska;Oskar Nowak;Lidia Karabon;Anna Pokryszko-Dragan;Anna Partyka;Anna Tomkiewicz;Jakub Ptaszkowski;Irena Frydecka;Ryszard Podemski;Jaroslaw Dybko;Malgorzata Bilinska.Journal of Neuroimmunology.2017,